Evidence map›Paper›PMID 42590326›Full record

ArticleMaterials (Basel, Switzerland)2026

A Problem-Setup-Centric Framework for Mixed-Variable Chemical Formulation Optimization with Customized Constraints.

Yingjun Zhang, Shaochen Chen, Suqi Gao, Pengcheng Xu, Wencong Lu

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yingjun ZhangDepartment of Chemistry, Shanghai University, Shanghai 200444, China.
Shaochen ChenHubei Institute of Aerospace Chemotechnology, Xiangyang 441003, China.
Suqi GaoHubei Institute of Aerospace Chemotechnology, Xiangyang 441003, China.
Pengcheng XuHubei Institute of Aerospace Chemotechnology, Xiangyang 441003, China.ORCID 0000-0001-5513-8072
Wencong LuDepartment of Chemistry, Shanghai University, Shanghai 200444, China.ORCID 0000-0001-5361-6122

Funding

Hubei Provincial Natural Science Foundation and Xiangyang Innovation and Development Joint Fund of China 2025AFD104
6 · The paper itself

Abstract

Chemical formulation design is a challenging multi-objective optimization problem involving mixed continuous and discrete variables, feasibility constraints, and limited experimental data. Existing virtual formulation generation methods are often restricted to interpolation within historically observed regions and therefore lack sufficient exploratory capability. In this work, a problem-setup-centric multi-objective optimization framework for virtual chemical formulation generation is proposed. The framework uses a pymoo-based mixed-variable evolutionary workflow to optimize machine-learning-predicted properties under application-specific objectives and constraints. One energetic-material formulation dataset and one steel-alloy composition dataset are used to evaluate the proposed approach. The generated Pareto solutions include candidates that remain similar to historical formulations and candidates that show greater statistical deviation from the historical data distribution. The t-SNE projections provide qualitative visualizations of local structural relationships, while Mahalanobis-distance and feature-distribution analyses characterize statistical deviation in the original feature space. Overall, this study provides a flexible and practical workflow for data-driven virtual formulation design with customized mixed-variable constraints.

Indexed as

multi-objective optimizationsurrogate modelingtolerance-aware designvirtual formulation generation

Identifiers

PMID42590326
PMCPMC13467574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.